Physiol. Genomics Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 13: 25-30, 2003; doi:10.1152/physiolgenomics.00124.2002
1094-8341/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by You, S.-A.
Right arrow Articles by Wang, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by You, S.-A.
Right arrow Articles by Wang, Q.
Received 24 September 2002; accepted in final form 13 January 2003.
Physiological Genomics 13:25-30 (2003)
1094-8341/03 $5.00 © 2003 American Physiological Society

Brief Communication

Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis

Sun-Ah You 1,2, Stephen R. Archacki 1,2,3, George Angheloiu 4, Christine S. Moravec 4, Shaoqi Rao 1,2, Michael Kinter 5, Eric J. Topol 1,2 and Qing Wang 1,2,3

1 Center for Molecular Genetics, Department of Molecular Cardiology, Cleveland Clinic Foundation, Cleveland 44195
2 Center for Cardiovascular Genetics, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland 44195
3 Department of Biology, Cleveland State University, Cleveland 44115
4 Kaufman Center for Heart Failure, Department of Cardiovascular Medicine, Cleveland, Ohio 44195
5 Department of Cell Biology, Cleveland Clinic Foundation, Cleveland, Ohio 44195

Coronary artery disease (CAD) is the leading cause of mortality and morbidity in developed nations. We hypothesized that CAD is associated with distinct patterns of protein expression in the coronary arteries, and we have begun to employ proteomics to identify differentially expressed proteins in diseased coronary arteries. Two-dimensional (2-D) gel electrophoresis of proteins and subsequent mass spectrometric analysis identified the ferritin light chain as differentially expressed between 10 coronary arteries from patients with CAD and 7 coronary arteries from normal individuals. Western blot analysis indicated significantly increased expression of the ferritin light chain in the diseased coronary arteries (1.41 vs. 0.75; P = 0.01). Quantitative real-time PCR analysis showed that expression of ferritin light chain mRNA was decreased in diseased tissues (0.70 vs. 1.17; P = 0.013), suggesting that increased expression of ferritin light chain in CAD coronary arteries may be related to increased protein stability or upregulation of expression at the posttranscriptional level in the diseased tissues. Ferritin light chain protein mediates storage of iron in cells. We speculate that increased expression of the ferritin light chain may contribute to pathogenesis of CAD by modulating oxidation of lipids within the vessel wall through the generation of reactive oxygen species. Our results provide in situ proteomic evidence consistent with the "iron hypothesis," which proposes an association between excessive iron storage and a high risk of CAD. However, it is also possible that the increased ferritin expression in diseased coronary arteries is a consequence, rather than a cause, of CAD.

coronary artery disease; sudden death; atherosclerosis; proteomics




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
A. Zarjou, V. Jeney, P. Arosio, M. Poli, P. Antal-Szalmas, A. Agarwal, G. Balla, and J. Balla
Ferritin Prevents Calcification and Osteoblastic Differentiation of Vascular Smooth Muscle Cells
J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1254 - 1263.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Liao, Z. Liu, J. Bao, Z. Zhao, J. Hu, X. Feng, R. Feng, Q. Lu, Z. Mei, Y. Liu, et al.
A proteomic study of the aortic media in human thoracic aortic dissection: Implication for oxidative stress
J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
S. C. Smith, E. C. Smith, M. L. Gilman, J. L. Anderson, and R. L. Taylor Jr.
Differentially Expressed Soluble Proteins in Aortic Cells from Atherosclerosis-Susceptible and Resistant Pigeons
Poult. Sci., July 1, 2008; 87(7): 1328 - 1334.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
L. U. Zimmerli, E. Schiffer, P. Zurbig, D. M. Good, M. Kellmann, L. Mouls, A. R. Pitt, J. J. Coon, R. E. Schmieder, K. H. Peter, et al.
Urinary Proteomic Biomarkers in Coronary Artery Disease
Mol. Cell. Proteomics, February 1, 2008; 7(2): 290 - 298.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
F. B. Hu
The Iron-Heart Hypothesis: Search for the Ironclad Evidence
JAMA, February 14, 2007; 297(6): 639 - 641.
[Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M. Mayr, J. Zhang, A. S. Greene, D. Gutterman, J. Perloff, and P. Ping
Proteomics-based Development of Biomarkers in Cardiovascular Disease: Mechanistic, Clinical, and Therapeutic Insights
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1853 - 1864.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. M. Blanco-Colio, J. L. Martin-Ventura, F. Vivanco, J.-B. Michel, O. Meilhac, and J. Egido
Biology of atherosclerotic plaques: What we are learning from proteomic analysis
Cardiovasc Res, October 1, 2006; 72(1): 18 - 29.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. J. Sloane, R. A. Lindner, S. S. Prasad, L. T. Sebastian, S. K. Pedersen, M. Robinson, P. T. Bye, D. W. Nielson, and J. L. Harry
Proteomic Analysis of Sputum from Adults and Children with Cystic Fibrosis and from Control Subjects
Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1416 - 1426.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Goralska, S. Nagar, L. N. Fleisher, and M. C. McGahan
Differential Degradation of Ferritin H- and L-Chains: Accumulation of L-Chain-Rich Ferritin in Lens Epithelial Cells
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3521 - 3529.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. P. McRedmond, S. D. Park, D. F. Reilly, J. A. Coppinger, P. B. Maguire, D. C. Shields, and D. J. Fitzgerald
Integration of Proteomics and Genomics in Platelets: A PROFILE OF PLATELET PROTEINS AND PLATELET-SPECIFIC GENES
Mol. Cell. Proteomics, February 1, 2004; 3(2): 133 - 144.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. R. Archacki, G. Angheloiu, X.-L. Tian, F. L. Tan, N. DiPaola, G.-Q. Shen, C. Moravec, S. Ellis, E. J. Topol, and Q. Wang
Identification of new genes differentially expressed in coronary artery disease by expression profiling
Physiol Genomics, September 29, 2003; 15(1): 65 - 74.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online